About Diana Li

Diana Li is a partner in Fangda’s life science team specialising in regulatory matters, licensing, mergers and acquisitions, private equity, foreign direct investment and general corporate matters. Diana is dedicated to providing services to clients in the pharmaceutical and medical device sectors, among other healthcare industry clients including multinational companies, Chinese companies and investment funds. She is a member of the IBA Life Science Committee and has been recognised as an upcoming tier-4 lawyer by Chambers China, in the life science and healthcare practice sectors, for the past few years.